-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Adial Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q2 2025.
- Adial Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $124K, a 38.7% decline year-over-year.
- Adial Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $729K, a 25.4% decline year-over-year.
- Adial Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $797K, a 54.4% decline from 2023.
- Adial Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.75M, a 48.2% decline from 2022.
- Adial Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.37M, a 20.4% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)